Table 4 Anthropometric measurements, serum zinc, and IGF 1 of the cholestatic patients before and after zinc supplementation
From: Zinc status in infants and children with cholestatic liver diseases and its effect on growth
Variables | Initial | After 4 months | P value |
|---|---|---|---|
MUAC Z-score (median (IQR), [range]) | − 1.5 (2), [− 5.9:0.9] | 1.5 (1.3), [− 3.7:0.6] | > 0.05 |
MUAC percentile (median (IQR), [range]) | 7 (41), [0.00:82] | 6 (23), [0.00:71] | > 0.05 |
TSF Z-score (median (IQR), [range]) | − 2.45 (1.8), [− 7.7:0.2] | − 2 (2.6), [− 5.09:0.1] | > 0.05 |
TSF percentile (median (IQR), [range]) | 1 (3), [0.00:58] | 2.5 (21), [0.00:55] | > 0.05 |
Weight Z-score (median (IQR), [range]) | − 1.2 (1.9), [− 5.5:6.3] | − 0.7 (1.9), [− 2.7:94] | > 0.05 |
Weight percentile (median (IQR), [range]) | 11.5 (37), [− 2.7:97] | 22 (53), [0.00:88] | > 0.05 |
Height (length) Z-score (median (IQR), [range]) | − 1.6 (2.6), [− 4.8:41] | − 0.5 (2.6), [− 2.5:16] | 0.01* |
Height (length) percentile (median (IQR), [range]) | 4 (31), [− 0.23:99] | 21 (58), [− 0.9:100] | 0.01* |
Serum Zn (mean ± SD) μg/l | 1252 ± 557 | 2223 ± 1042 | 0.001* |
IGF-1 (median (IQR), [range]) ng/ml | 54 (118), [10:780] | 346 (370), [50:825] | 0.001* |